CJC + IPA 10 MG

CJC + IPA 10 MG

Single Vial
$99.00 USD
Skip to product information
CJC + IPA 10 MG
In stock

Metabolic Series

CJC + IPA 10 MG

Composition
  • CJC-1295 (No DAC) 10 mg
  • Ipamorelin 10 mg

CJC-1295 paired with Ipamorelin has become a subject of interest in scientific research on peptide signaling. CJC-1295 provides extended GHRH activity, while Ipamorelin offers a highly selective ghrelin-mimetic profile. Researchers often investigate this combination to better understand growth hormone dynamics in controlled models.

Vials
$99.00 USD
Shipping calculated at checkout.

Research use only

All products sold on this website are for research and laboratory purposes only. They are not for human or animal use, including injection, ingestion, or any other form of administration. These products are not FDA-approved to diagnose, treat, cure, or prevent any disease. By purchasing, you certify they will be used solely for legitimate laboratory research and not for human or animal consumption.

Purity CJC-1295 (No DAC) 10 mg and Ipamorelin 10 mg

Certificate of Analysis

Third-party tested for 99% purity, ID, quantity.

History Of CJC + IPA 10 MG

The concept of the CJC-1295 + Ipamorelin blend stems from parallel developments in peptide research aimed at exploring growth hormone modulation. CJC-1295, a synthetic analog of growth hormone–releasing hormone (GHRH), was developed in the early 2000s to extend the half-life and activity of natural GHRH fragments for research into growth hormone and IGF-1 pathways. Meanwhile, Ipamorelin—a selective ghrelin receptor agonist—emerged from studies in the 1990s investigating ghrelin mimetics and their ability to stimulate growth hormone release with minimal off-target hormonal effects. Together, these peptides became of interest for laboratory research into growth hormone regulation, recovery, and metabolic processes.

Research Overview Of CJC + IPA 10 MG

The CJC-1295 + Ipamorelin blend combines two peptides studied for their effects on growth hormone release. CJC-1295, a GHRH analog, is associated with sustained increases in growth hormone and IGF-1, supporting repair and recovery. Ipamorelin, a selective ghrelin receptor agonist, promotes growth hormone release without significantly affecting other hormones. Together, they may provide complementary support for improved body composition, recovery, and anti-aging benefits in clinical research.

Investigated for
  • Growth hormone release signalling pathways
  • Metabolic regulation research models
  • Cellular recovery and repair mechanisms
  • Endocrine rhythm and hormonal signaling studies

CJC-1295 Structure

CAS #: 446036-97-1

Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂

Molecular Weight: 3367.9 g/mol

PubChem ID: 91976842

Ipamorelin Structure

CAS #: 170851-70-4

Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂

Molecular Weight: 3367.9 g/mol

PubChem ID: 91976842

Specification
  • Purity: ≥99%, third-party tested.
  • Batch / Lot: Provided on vial label and confirmed at delivery.
  • Certificate of Analysis (per batch): Provided at delivery for the shipped lot/batch.
Storage & Handling

Store in a cool, dry, dark place and minimize exposure to heat, moisture, light, and air. Avoid unnecessary temperature changes and reseal promptly after use. For full best practices and detailed guidance, read our Storage & Handling page.

Need Help?

Send us a message

Contact Us

💬 24/7 Support

🇺🇸 Manufactured in USA

Verified Purity

Recommended Compounds

feature-item-1
High Purity Standards

≥99% purity when applicable.

feature-item-2
COA Per Batch

Batch documentation available by lot/batch.

feature-item-3
Third-Party Lab Tested

Independent testing and verification.

feature-item-4
Clear Storage Guidance

Lab handling, clearly outlined